Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-007004

CHIEF FINANCIAL OFFICER gave up 291 shares (to pay taxes)

  • CHIEF FINANCIAL OFFICER acquired 990 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ragosa Mark CHIEF FINANCIAL OFFICER 2023-04-26 Option exercise +990 12,705 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2023-04-26 Shares withheld for taxes −291 $11.15 $3,245 12,414 D
Derivatives
Ragosa Mark CHIEF FINANCIAL OFFICER 2023-04-26 Option exercise · Restricted Share Unit +990 1,981 D
Loading xslF345X04/form4-04282023_040401.xml…